Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Business Practice, Trends & Forecasts

Hiding in Plain Sight

It is well known in the pharma industry – and among law enforcers – that counterfeit drugs are a growing problem, but Western consumers remain blissfully unaware for the most part. Despite a few high profile cases – for example, fake Avastin given to US cancer patients – the main burden falls on developing countries. Frequent shortages of life-saving drugs force doctors to turn to unofficial ‘gray market’ sources, while illegal (and potentially dangerous) fakes are sold direct to consumers in markets or on the street. Just this week, the press reported that an INTERPOL swoop in South Africa had seized 150 tons of fake medicines, arrested 550 people and closed 20 pharmacies. The World Health Organization (WHO) estimates that 100,000 deaths a year in Africa are linked to the counterfeit drug trade. That said, counterfeit medicines are not always inactive or dangerous – some are simply generics, mislabeled as brand-name drugs. Critics have argued that pursuing these ‘harmless’ counterfeits takes resources away from combating the real danger of falsified medicine (1). But it is hard to draw a clear distinction between the two – and is it unlikely that those already engaged in an illegal activity will feel compelled to stick to the stringent quality and safety standards of licensed drug manufacturers.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register